UPDATE: Baird Assumes Syndax Pharmaceuticals (SNDX) at Outperform
Tweet Send to a Friend
(Updated - June 4, 2021 5:15 AM EDT)
Baird analyst Joel Beatty assumes coverage on Syndax Pharmaceuticals (NASDAQ: SNDX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty assumes coverage on Syndax Pharmaceuticals (NASDAQ: SNDX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
